Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Delia, Mario
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
B
Trecarichi EMaria
,
Giuliano G
,
Cattaneo C
,
Ballanti S
,
Criscuolo M
,
Candoni A
,
Marchesi F
,
Laurino M
,
Dargenio M
,
Fanci R
, et al.
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
PLoS One. 2019;14(10):e0224465.
PubMed
Google Scholar
Trecarichi EMaria
,
Giuliano G
,
Cattaneo C
,
Ballanti S
,
Criscuolo M
,
Candoni A
,
Marchesi F
,
Laurino M
,
Dargenio M
,
Fanci R
, et al.
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Int J Antimicrob Agents. 2023:106806.
PubMed
Google Scholar
D
Salmanton-García J
,
Marchesi F
,
Farina F
,
Weinbergerova B
,
Itri F
,
Dávila-Valls J
,
Martín-Pérez S
,
Glenthøj A
,
Hersby DStampe
,
da Silva MGomes
, et al.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine. 2024;71:102553.
PubMed
Google Scholar
Aiello TFrancesco
,
Salmanton-García J
,
Marchesi F
,
Weinbergerova B
,
Glenthoj A
,
van Praet J
,
Farina F
,
Dávila-Valls J
,
Martín-Pérez S
,
El-Ashwah S
, et al.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica. 2024.
PubMed
Google Scholar
I
Delia M
,
Carluccio P
,
Mestice A
,
Chiusolo P
,
Metafuni E
,
Bellesi S
,
Arpinati M
,
Milone GAntonio
,
Martino M
,
Mazza P
, et al.
The impact of graft CD3/Tregs ratio on aGvHD and post-transplant outcome: a prospective multicenter study on patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
Del Principe MIlaria
,
Dragonetti G
,
Conti A
,
Verga L
,
Ballanti S
,
Fanci R
,
Candoni A
,
Marchesi F
,
Cattaneo C
,
Lessi F
, et al.
Invasive aspergillosis in relapsed/refractory acute myeloid leukemia patients. Results from SEIFEM 2016-B survey.
Mycoses. 2021.
PubMed
Google Scholar
M
Salmanton-García J
,
Marchesi F
,
Koehler P
,
Weinbergerova B
,
Colović N
,
Falces-Romero I
,
Buquicchio C
,
Farina F
,
VAN Praet J
,
Biernat MM
, et al.
MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY.
Int J Antimicrob Agents. 2023:106952.
PubMed
Google Scholar
N
Candoni A
,
Lazzarotto D
,
Ferrara F
,
Curti A
,
Lussana F
,
Papayannidis C
,
Del Principe MIlaria
,
Bonifacio M
,
Mosna F
,
Delia M
, et al.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory t-cell acute lymphoblastic leukemia/lymphoma. the campus-all study.
Am J Hematol. 2020.
PubMed
Google Scholar
P
Menna P
,
Marchesi F
,
Cattaneo C
,
Candoni A
,
Delia M
,
Nadali G
,
Vatteroni A
,
Pasciolla C
,
Perrone S
,
Verga L
, et al.
Posaconazole and midostaurin in patients with FLT3-mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study.
Clin Transl Sci. 2023.
PubMed
Google Scholar